Navigation Links
New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
Date:6/30/2008

n vasodilatory side effects of prostacyclin and its analogs (e.g., headache, nausea, dizziness, flushing) and those commonly associated with the inhalation route of administration (e.g., cough and throat irritation). These side effects were mostly mild or moderate in severity and were not dose-limiting in the majority of patients treated with ITRE.

About United Therapeutics

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.

About Lung Rx

Lung Rx is a biotechnology company focused on unmet medical needs in pulmonary medicine and pulmonary delivery of innovative therapeutic products.

Forward-looking Statements

Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include our expectation that the ITRE NDA will be subject to a 10- to 12-month review period and our belief that ITRE will be a desirable option for PAH patients once it has been approved for marketing. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, which could cause actual results to differ materially from anticipated results. These risks and uncertainties include, among others, the failure of ITRE and the nebulizers used to administer ITRE to receive regulatory approvals on the schedule expected; the uncertainties of launching a new product on a global scale following receipt of regulatory approvals, if received, due to misestimates of the time and resources required to do so, or for other reasons; the failure of ITRE to receive favorable pricing or reimbursement; the possible
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
2. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
3. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
4. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
5. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
6. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
7. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
8. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
9. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
10. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
11. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014   COTA, Inc. today announced it ... Series A funding round led by Horizon Healthcare Services, ... first big data platform designed by practicing oncologists to ... cancer care in support of healthcare,s new value-based reimbursement ... development of the COTA platform, hire biostatisticians, outcome analysts, ...
(Date:9/23/2014)... , Sept. 23, 2014 A case report ... a SynCardia temporary Total Artificial Heart into a patient ... ventricles were reversed, along with other abnormalities. ... modifying the SynCardia Total Artificial Heart to treat a ... report and video in the Journal of Visualized Experiments ...
(Date:9/23/2014)... 2014  As physicians seek information about drugs ... to learn about new therapies or ask questions ... new report by global sales and marketing consultants ... via a customized mix of digital media and ... to engage with physicians. And, productive engagement with ...
Breaking Medicine Technology:COTA Closes $3.7M of Planned $7M Series A Funding Round to Transform Cancer Outcomes and Reimbursement 2COTA Closes $3.7M of Planned $7M Series A Funding Round to Transform Cancer Outcomes and Reimbursement 3COTA Closes $3.7M of Planned $7M Series A Funding Round to Transform Cancer Outcomes and Reimbursement 41st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 21st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 31st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 4As sales reps see doors close for in-person visits with physicians, digital doors open communication 2As sales reps see doors close for in-person visits with physicians, digital doors open communication 3As sales reps see doors close for in-person visits with physicians, digital doors open communication 4As sales reps see doors close for in-person visits with physicians, digital doors open communication 5
... MORRISTOWN, N.J., March 25, 2011 Watson Pharmaceuticals, Inc. ... pharmaceutical company, today confirmed that it has received a ... the Federal Circuit related to its ongoing patent challenge ... seeking FDA approval to market a generic version of ...
... Asymchem Life Science (Tianjin) Co. Ltd, a leading research-based ... industry, with sites in the U.S. and China, is pleased ... Vice President of Quality Assurance as of March 1, 2011. ... 18 years, experience in the pharmaceutical industry (early and late ...
Cached Medicine Technology:Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge 2Mr. Robert Andrews Joins Asymchem Life Science (Tianjin) Co. Ltd. as Vice President of Quality Assurance 2
(Date:9/23/2014)... remedy stress: You just need a breath of fresh air. ... , Turns out all those things combined may in fact ... new large scale study suggests. , Group nature walks are ... mental health and well-being, according to the study conducted by ... James Hutton Institute, and Edge Hill University in the United ...
(Date:9/23/2014)... a minimally invasive procedure to remove the gallbladder, is ... U.S. Yet medical centers around the country vary in ... quickly into surgery while others wait. , In a ... of Surgery , researchers found gallbladder removal surgery can ... patients into the operating room at night. , ...
(Date:9/23/2014)... UPTON, NYMuch of our understanding of how living things ... that catalyze the processes of life, the receptors that ... the nucleic acids DNA and RNA that carry genetic ... To give scientists unprecedented access to these structural details, ... of Health (NIH) and the U.S. Department of Energy ...
(Date:9/23/2014)... ADOMANI, Inc. has announced that industry ... He is a 13-year veteran in the school, commercial and ... A-Z Bus Sales of Colton, California. While with A-Z Mr. ... top line revenues, profit and market penetration by double digits. ... to all-electric or plug-in hybrid vehicle conversions. They have ...
(Date:9/23/2014)... of Cancer presents detailed reports on the wide ... Survivorship Summit held this past January in Brussels, Belgium. ... treatments has boosted survival rates of patients with cancer ... of cancer survivors. Despite this good news, cancer survivors ... adverse treatment effects and some must also deal with ...
Breaking Medicine News(10 mins):Health News:Beating stress outdoors? Nature group walks may improve mental health 2Health News:Study finds gallbladder surgery can wait 2Health News:New NIH/DOE grant for life science studies at NSLS-II 2Health News:New NIH/DOE grant for life science studies at NSLS-II 3Health News:ADOMANI Announces Jim Reynolds to Take Over as President and CEO 2
... sufficiency, new, antimicrobial-susceptibility system/panels for MRSA and other pathogens, ... and enhanced automated laboratory systems, ... will also be on view, WASHINGTON, July 29 ... will see Magellan Biosciences, continued,emergence as a new leader in ...
... people with disabilities when facing increasing healthcare costs, including added ... ... Belleville, IL (PRWEB) July 29, 2008 –- Rising ... a financial overload for families, according to http://allsup.com/Home.aspx ...
... Healthcare of Atlanta Signs Multi-Year Agreement with PureWellness to Provide ... ... Burlington, VT (PRWEB) July 29, 2008 -- PureWellness, ... solutions], announced it has signed an agreement with Children,s Healthcare ...
... a breakthrough test on its mesothelioma blog, which will allow early detection ... cancer kills a patient so quickly is due to the fact that ... ... -- LegalView, the most comprehensive legal resource available on the web, informed ...
... Database Now Offers Early Access to Research From ... and citation database of,peer-reviewed literature, today announced that ... papers published,prior to being printed, from journals produced ... Group (NPG). In the fall, AiPs,from BioMed Central ...
... age of your neighborhood may influence your risk of obesity, according ... The study, to be ... Preventive Medicine , linked the body mass index (BMI) of nearly ... The study found that residents were at less risk of being ...
Cached Medicine News:Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 2Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 3Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 4Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 5Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 2Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 3Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 4Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 5Health News:Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program 2Health News:Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program 3Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 2Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 3Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 4Health News:Scopus Adds Pre-Print Research Abstracts From Four Prestigious Publishers 2Health News:Scopus Adds Pre-Print Research Abstracts From Four Prestigious Publishers 3Health News:This old healthy house 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
... The economical way to order tips. ... of 1000 tips). Also available in easy-to-open, ... pack. Bulk Packs are sealed with a ... for quick access to Gilsons Diamond Tips. ...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
Medicine Products: